Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Fusion of road geometry model information gathered from disparate sources
LED lighting module
Extreme ultraviolet light generation apparatus
Gestures for presentation of different views of a system diagram
Display device and method of repairing display device
Accordion bioreactor
Baseball player stationery tab
  Randomly Featured Patents
Apparatus for converting image outline data into dot data representative of image dots
Electrical connector receptacle with module kickout mechanism
Thermoplastic cement composition and process for the preparation of molded article thereof
Antibody selective for DR4 and uses thereof
Packaging carton
Primary and secondary cell group configuration
Fluid catalytic cracking
Flowmetering apparatus
Semiconductor devices including a multi-well and split-gate non-volatile memory transistor structure
Housing for a fluid transfer machine and methods of use